261 related articles for article (PubMed ID: 29066189)
21. Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria.
Utazi CE; Aheto JMK; Wigley A; Tejedor-Garavito N; Bonnie A; Nnanatu CC; Wagai J; Williams C; Setayesh H; Tatem AJ; Cutts FT
Vaccine; 2023 Jan; 41(1):170-181. PubMed ID: 36414476
[TBL] [Abstract][Full Text] [Related]
22. Avoiding missed opportunities for immunization in the Central African Republic: potential impact on vaccination coverage.
Kahn JG; Mokdad AH; Deming MS; Roungou JB; Boby AM; Excler JL; Waldman RJ
Bull World Health Organ; 1995; 73(1):47-55. PubMed ID: 7704925
[TBL] [Abstract][Full Text] [Related]
23. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.
Higgins JP; Soares-Weiser K; López-López JA; Kakourou A; Chaplin K; Christensen H; Martin NK; Sterne JA; Reingold AL
BMJ; 2016 Oct; 355():i5170. PubMed ID: 27737834
[TBL] [Abstract][Full Text] [Related]
24. Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates.
Dietz VJ; Stevenson J; Zell ER; Cochi S; Hadler S; Eddins D
Arch Pediatr Adolesc Med; 1994 Sep; 148(9):943-9. PubMed ID: 8075738
[TBL] [Abstract][Full Text] [Related]
25. Global Routine Vaccination Coverage, 2018.
Peck M; Gacic-Dobo M; Diallo MS; Nedelec Y; Sodha SV; Wallace AS
MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(42):937-942. PubMed ID: 31647786
[TBL] [Abstract][Full Text] [Related]
26. Using the theoretical domains framework to explore reasons for missed opportunities for vaccination among children in Kano, Nigeria: a qualitative study in the pre-implementation phase of a collaborative quality improvement project.
Adamu AA; Uthman OA; Gadanya MA; Cooper S; Wiysonge CS
Expert Rev Vaccines; 2019 Aug; 18(8):847-857. PubMed ID: 31304839
[No Abstract] [Full Text] [Related]
27. Evaluation of invalid vaccine doses in 31 countries of the WHO African Region.
Akmatov MK; Kimani-Murage E; Pessler F; Guzman CA; Krause G; Kreienbrock L; Mikolajczyk RT
Vaccine; 2015 Feb; 33(7):892-901. PubMed ID: 25523526
[TBL] [Abstract][Full Text] [Related]
28. Determinants of uptake of third doses of oral polio and DTP vaccines in the Ibadan North Local Government Area of Nigeria.
Fatiregun AA; Etukiren EE
Int Health; 2014 Sep; 6(3):213-24. PubMed ID: 24844557
[TBL] [Abstract][Full Text] [Related]
29. Childhood full and under-vaccination in Nigeria, 2013.
McGavin ZA; Wagner AL; Carlson BF; Power LE; Eboreime E; Boulton ML
Vaccine; 2018 Nov; 36(48):7294-7299. PubMed ID: 30340882
[TBL] [Abstract][Full Text] [Related]
30. Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
Wedlock PT; Mitgang EA; Siegmund SS; DePasse J; Bakal J; Leonard J; Welling J; Brown ST; Lee BY
Vaccine; 2018 Sep; 36(39):5879-5885. PubMed ID: 30146404
[TBL] [Abstract][Full Text] [Related]
31. The faces behind vaccination: unpacking the attitudes, knowledge, and practices of staff of Cameroon's Expanded program on Immunization.
Saidu Y; Gu J; Ngenge BM; Nchinjoh SC; Adidja A; Nnang NE; Muteh NJ; Zambou VM; Mbanga CM; Agbor VN; Ousmane D; Njoh AA; Flegere J; Diack D; Wiwa O; Montomoli E; Clemens SAC; Clemens R
Hum Resour Health; 2023 Nov; 21(1):88. PubMed ID: 37957695
[TBL] [Abstract][Full Text] [Related]
32. Household experience and costs of seeking measles vaccination in rural Guinea-Bissau.
Byberg S; Fisker AB; Rodrigues A; Balde I; Enemark U; Aaby P; Benn CS; Griffiths UK
Trop Med Int Health; 2017 Jan; 22(1):12-20. PubMed ID: 27717100
[TBL] [Abstract][Full Text] [Related]
33. Descriptive study of measles vaccination second dose reporting and barriers to improving coverage in six districts in Malawi.
Chirwa G; Wilkins KA; Mercer DJ
Pan Afr Med J; 2020; 35(Suppl 1):5. PubMed ID: 32373256
[TBL] [Abstract][Full Text] [Related]
34. Contribution of polio eradication initiative to strengthening routine immunization: Lessons learnt in the WHO African region.
Anya BM; Moturi E; Aschalew T; Carole Tevi-Benissan M; Akanmori BD; Poy AN; Mbulu KL; Okeibunor J; Mihigo R; Zawaira F
Vaccine; 2016 Oct; 34(43):5187-5192. PubMed ID: 27396492
[TBL] [Abstract][Full Text] [Related]
35. Country-level predictors of vaccination coverage and inequalities in Gavi-supported countries.
Arsenault C; Johri M; Nandi A; Mendoza Rodríguez JM; Hansen PM; Harper S
Vaccine; 2017 Apr; 35(18):2479-2488. PubMed ID: 28365251
[TBL] [Abstract][Full Text] [Related]
36. Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa.
Manandhar P; Wannemuehler K; Danovaro-Holliday MC; Nic Lochlainn L; Shendale S; Sodha SV
Vaccine; 2023 Jan; 41(1):61-67. PubMed ID: 36396512
[TBL] [Abstract][Full Text] [Related]
37. Use of a new combined vaccine in pediatric practices.
Freed GL; Cowan AE; Clark SJ; Santoli J; Bradley J
Pediatrics; 2006 Aug; 118(2):e251-7. PubMed ID: 16831895
[TBL] [Abstract][Full Text] [Related]
38. The effect of epidemic measles on immunization rates.
Goldstein KP; Philipson TJ; Joo H; Daum RS
JAMA; 1996 Jul; 276(1):56-8. PubMed ID: 8667540
[TBL] [Abstract][Full Text] [Related]
39. Public-sector vaccination efforts in response to the resurgence of measles among preschool-aged children--United States, 1989-1991.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1992 Jul; 41(29):522-5. PubMed ID: 1630430
[TBL] [Abstract][Full Text] [Related]
40. The influence of provider behavior, parental characteristics, and a public policy initiative on the immunization status of children followed by private pediatricians: a study from Pediatric Research in Office Settings.
Taylor JA; Darden PM; Slora E; Hasemeier CM; Asmussen L; Wasserman R
Pediatrics; 1997 Feb; 99(2):209-15. PubMed ID: 9024448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
